Europe heavily relies on US plasma imports for essential medicines, facing growing demand and low self-sufficiency rates.
🔗 Read the article on elconfidencial.com
Also republished by:
Der Standard - GER
[This is an automatically generated summary, for reference only]
Europe heavily relies on the United States for plasma, a vital component of blood used to produce essential medicines like albumin and immunoglobulins. To achieve relative self-sufficiency, Europe needs millions of additional blood and plasma donors. The demand for plasma exceeds current EU collection capacity, leading to significant imports from the US, which is the world’s main exporter of plasma-derived drugs. While some countries have higher collection rates, many remain dependent on international supply chains. Immunoglobulins are particularly critical as few alternatives exist, and their demand is rising due to new uses, expanded indications, and improved diagnosis. Although research into immunological reorganization is ongoing, immediate priority must be placed on increasing donations through public awareness campaigns and better donor access. Spain, for instance, only covers about a quarter of its needs for plasma production.
